Tiziana Life Sciences Ltd (TLSA)

Dec 17, 2024

Tiziana Life Sciences doses first Alzheimer’s patient with intranasal foralumab - Proactive Investors Australia

Dec 17, 2024

Dec 17, 2024

Tiziana Life Sciences Announces First Patient with Moderate Alzheimer's Disease Dosed with Intranasal Foralumab - The Manila Times

Dec 17, 2024

Dec 17, 2024

Tiziana Life Sciences Launches Novel Alzheimer's Treatment Trial with Groundbreaking Intranasal Therapy - StockTitan

Dec 17, 2024

Dec 13, 2024

Tiziana Life Sciences Ltd (NASDAQ:TLSA) Sees Large Drop in Short Interest - MarketBeat

Dec 13, 2024

Dec 05, 2024

3 US Penny Stocks With Market Caps Under $200M To Consider - Simply Wall St

Dec 05, 2024

Dec 05, 2024

17% Gain Today – This Stock Isn’t Done Yet - RagingBull

Dec 05, 2024

Dec 05, 2024

Tiziana Life Sciences expands Phase 2 trial for non-active SPMS - Yahoo Finance

Dec 05, 2024

Dec 05, 2024

Tiziana broadens Phase 2 trial for MS therapy By Investing.com - Investing.com Canada

Dec 05, 2024

Dec 05, 2024

Tiziana Life Sciences expands Phase 2 MS trial to additional top US medical institutions - Proactive Investors Australia

Dec 05, 2024

Dec 04, 2024

U.S. Dollar Index (DXY) QuotePress Release - The Globe and Mail

Dec 04, 2024

Dec 04, 2024

PHLX Canadian Dollar (XDC) QuotePress Release - The Globe and Mail

Dec 04, 2024

Dec 04, 2024

TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail

Dec 04, 2024

Dec 04, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Dec 04, 2024

Dec 04, 2024

Tiziana broadens Phase 2 trial for MS therapy - Investing.com India

Dec 04, 2024

Dec 04, 2024

S&P 500 Communication Services [Sector] (SRTS) QuotePress Release - The Globe and Mail

Dec 04, 2024

Dec 04, 2024

S&P 500 Index (INX) QuotePress Release - The Globe and Mail

Dec 04, 2024

Dec 04, 2024

S&P 500 ESG (ESG) QuotePress Release - The Globe and Mail

Dec 04, 2024

Dec 04, 2024

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers - The Manila Times

Dec 04, 2024

Dec 04, 2024

Tiziana Life Sciences Expands Breakthrough MS Drug Trial to Elite U.S. Medical Centers - StockTitan

Dec 04, 2024

Dec 04, 2024

Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 3.7%Here's What Happened - MarketBeat

Dec 04, 2024

Dec 04, 2024

Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 3.7% – Here’s What Happened - Defense World

Dec 04, 2024

Nov 20, 2024

Tiziana Life Sciences Secures ALS Trial Funding - Yahoo Finance

Nov 20, 2024

Nov 19, 2024

Tiziana Life Sciences secures grant for ALS trial - Proactive Investors USA

Nov 19, 2024

Nov 19, 2024

Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association - The Manila Times

Nov 19, 2024

Nov 19, 2024

Tiziana Life Sciences Secures ALS Association Grant for Breakthrough Foralumab Trial | TLSA Stock News - StockTitan

Nov 19, 2024

Nov 12, 2024

Tiziana Life Sciences Ltd (NASDAQ:TLSA) Sees Large Growth in Short Interest - MarketBeat

Nov 12, 2024

Nov 02, 2024

Tiziana Life Sciences CEO discusses foralumab potential to enhance OzempicICYMI - Proactive Investors USA

Nov 02, 2024

Nov 01, 2024

Tiziana Life Sciences to showcase breakthrough therapies at BIO-Europe 2024 Conference - Proactive Investors UK

Nov 01, 2024

Nov 01, 2024

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data - The Manila Times

Nov 01, 2024

Oct 31, 2024

Tiziana Life Sciences secures funding to advance development of MS and Alzheimer’s therapy - Proactive Investors USA

Oct 31, 2024

Oct 31, 2024

Tiziana Life Sciences Plans Share Sale with Jefferies - MSN

Oct 31, 2024

Oct 31, 2024

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million - The Manila Times

Oct 31, 2024

Oct 31, 2024

Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study - GlobeNewswire

Oct 31, 2024

Oct 30, 2024

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million - GlobeNewswire Inc.

Oct 30, 2024

Oct 30, 2024

Tiziana reports progress in obesity inflammation study By Investing.com - Investing.com South Africa

Oct 30, 2024

Oct 30, 2024

Tiziana Life Sciences : announces plans for clinical development of foralumab, the company’s fully human CD3 antibody - Marketscreener.com

Oct 30, 2024

Oct 30, 2024

Tiziana Life Sciences' Semaglutide combo shows potential in obesity-related liver inflammation - Proactive Investors USA

Oct 30, 2024

Oct 30, 2024

TLSATiziana Life Sciences Ltd. Common Shares Latest Stock News & Market Updates - StockTitan

Oct 30, 2024

Oct 30, 2024

Tiziana Life Sciences reports promising preclinical results for novel combination therapy targeting obesity - Proactive Investors UK

Oct 30, 2024

Oct 30, 2024

Tiziana reports progress in obesity inflammation study - Investing.com

Oct 30, 2024

Oct 30, 2024

Proactive news headlines: Helix, Hemogenyx, DEC, Ananda, Thor Energy, Bradda Head and more - Proactive Investors UK

Oct 30, 2024

Oct 28, 2024

Discover October 2024's Promising US Penny Stocks - Simply Wall St

Oct 28, 2024

Oct 20, 2024

Micron Technology (MU-Q) QuotePress Release - The Globe and Mail

Oct 20, 2024

Oct 19, 2024

Tiziana Life Sciences Advances with Promising Drug Trials - Yahoo Finance

Oct 19, 2024

Oct 18, 2024

Tiziana Life Sciences reports interim results, updates on programs - Investing.com India

Oct 18, 2024